Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Share-based Compensation (2012 - 2026)

Precigen (PGEN) posted quarterly Share-based Compensation of $146000.0 for Q1 2026, down 94.55% year-over-year from $2.7 million in Q1 2025, and down 93.25% quarter-over-quarter from $2.2 million in Q4 2025.

Analysis

Precigen (PGEN) Share-based Compensation (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Share-based Compensation for 15 consecutive years, with $146000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Share-based Compensation fell 94.55% year-over-year to $146000.0; the TTM figure through Mar 2026 stood at $8.3 million (down 12.88% YoY), while the FY2025 annual figure was $10.9 million, up 14.73% from the prior year.
  • Share-based Compensation fell to $146000.0 in Q1 2026 per PGEN's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.9 million in Q3 2025 and bottomed at -$7.6 million in Q4 2023.
  • Historically, Share-based Compensation has averaged $1.8 million across 5 years, with a median of $2.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 445.07% — and 2024, when it surged 186.47%.
  • Precigen's Share-based Compensation stood at $2.2 million in 2022, then sank by 445.07% to -$7.6 million in 2023, then surged by 137.57% to $2.9 million in 2024, then decreased by 24.5% to $2.2 million in 2025, then sank by 93.25% to $146000.0 in 2026.
  • Business Quant data shows PGEN's Share-based Compensation at $146000.0 in Q1 2026, $2.2 million in Q4 2025, and $6.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 3.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.58 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 4.39 Mn
Jun 30, 2025 1.64 Mn
Mar 31, 2025 2.68 Mn
Dec 31, 2024 2.87 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 1.96 Mn
Mar 31, 2024 2.58 Mn
Dec 31, 2023 2.26 Mn
Sep 30, 2023 2.31 Mn
Jun 30, 2023 2.19 Mn
Mar 31, 2023 3.13 Mn
Dec 31, 2022 2.21 Mn
Sep 30, 2022 2.13 Mn
Jun 30, 2022 2.31 Mn
Mar 31, 2022 3.56 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 2.49 Mn